
Alnylam Pharmaceuticals, Inc.
USD301.43
+7.91 (+2.69%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$296.82
Prev. Close
$293.52
Day Low
$295.18
Day High
$302.74
52W Low
$273.11
52W High
$495.55
Market Cap
$40.24B
Volume
0.15M
| 1 May 2026 |
| Wells Fargo |
| Equal Weight |
| Equal Weight |
| maintain |
| 1 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 13 Apr 2026 | Truist Securities | Buy | Buy | maintain |
| 25 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 25 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 16 Mar 2026 | Jefferies | Buy | Hold | downgrade |
| 18 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |